Mylan NV (NASDAQ:MYL) continues to collapse off the EpiPen fiasco. While minimal to their net revenues and profit, the negative press and public scorn is causing massive investor selling. That is where I look to step up and score a great swing trade by buying. The first step is to look at the stock chart and see the support level. I have been eyeing Mylan for days now and it finally hit a major support level at $40.00. The key is the long term trend line conneting the lows going back to October 2011. This gives a good foundation to expect a bounc trade. I am buying and should enjoy some nice profits next week.

By Annabelle Trader